Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists uncover new potential treatment for Inflammatory Bowel Disease

15.01.2008
Irish scientists have discovered a new potential therapeutic approach to Inflammatory Bowel Disease (IBD), a chronic debilitating disease involving inflammation of the intestine which affects more than 15,000 people in Ireland and millions of people worldwide.

People suffering from IBD can experience an array of symptoms ranging from mild discomfort to debilitating disease requiring surgical removal of large parts of the intestine. Current therapeutic options in IBD are very limited and surgery is often the only option.

In the new discovery published in the scientific journal Gastroenterology, the Irish scientists have demonstrated that they can almost completely reverse the symptoms of IBD in a disease model using a new class of drugs known as hydroxylase inhibitors.

“Under normal conditions our gastro-intestinal tract is lined with cells that block the contents of the gut from leaking into the intestine,” explains Professor Cormac Taylor from the UCD Conway Institute, University College Dublin, one of the principal scientists involved in the discovery. “However, when a person is suffering from IBD this barrier is broken and the contents of the gut leak out into surrounding areas.”

“When we applied the new drugs, the gut was tricked into thinking that it was being deprived of oxygen and this activated protective pathways which in turn prevented the death of the cells that line the gastrointestinal tract,” continues Professor Taylor.

While completing their investigation, the Irish researchers became aware of a similar study taking place at the University of Colorado, Denver. This study appears as an accompanying article in the same issue of Gastroenterology. The US study, while using a different hydroxylase inhibitor, supports the Irish scientist’s research findings.

The Irish and US research groups will now begin a collaborative investigation to bring the discovery to the next stage which involves developing a new therapeutic which can be delivered safely to humans.

“By working in collaboration with Sigmoid Biotechnologies, a Dublin based drug delivery company, we intend to focus on developing methods to safely deliver these drugs to their intended target in the inflamed gut,” says Professor Taylor.

“These findings show that cross-university partnerships adopted by the new generation of Science Foundation Ireland funded Irish scientists will help to drive Ireland’s future knowledge economy,” says Professor Padraic Fallon, SFI Stokes Professor, TCD School of Medicine, Trinity College Dublin, the other principal research scientist involved in the Irish discovery.

“If Ireland is to compete at the forefront of scientific discoveries and to develop partnerships with the international biotechnology sector, our scientist must work together in synergy,” continues Professor Fallon.

The Irish research groups led by Professor Taylor at University College Dublin and Dr Fallon at Trinity College Dublin have recently received independent investigator awards from Science Foundation Ireland totalling over €1 million each.

Dominic Martella | alfa
Further information:
http://www.ucd.ie

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>